WRIB 2026: Powering Bioanalysis from Discovery to the Clinic
Because Every Moment Matters
Bioanalytical services experts from Charles River are looking forward to welcoming you to our booth at the 20th WRIB (Workshops on Recent Issues in Bioanalysis).
This year’s workshop gathers the industry’s top scientific and regulatory minds, sharing their knowledge, helping you to gain a competitive edge in a fast-moving bioanalytical landscape.
Stop by Booth #27 to speak with our experts and discover how we can power your studies with scale and expertise at every phase of drug development.
Monday, April 16, 2026 | 7:00 a.m. – 5:45 p.m. (CST)
Leveraging Multiparameter Flow Cytometry and ELISpot to Identify and Characterize Vaccine Induced CD8⁺ T Cell Subpopulations
Speaker: Marie‑Soleil Piche, Senior Director, Immunology
This presentation explores recent advances in flow cytometry and ELISpot that enhance single‑cell resolution through increased multiplexing, improved sensitivity, and integration with microfluidics and AI/ML. It also highlights optimized PBMC pre‑treatment strategies and the role of ELISpot as the gold standard for detecting low‑frequency antigen‑specific T cells, supporting high‑throughput immune assessment in gene, cell, and vaccine therapy development.
| When Biology Matters: The Critical Role of Calcium, Parallelism, and Extraction Conditions in Calprotectin Measurement from Large Animal Feces Sophie Cotton, Senior Scientific Director, Charles River Biomarkers |
| Single Well Versus Duplicate Well Biomarker Analysis: A Data Driven Approach to Method Selection in Preclinical Biomarker Workflows Adesola Olatunde, Manager, Charles River Immunology |
| When Biology Matters: Developing an ELISA for the Quantification of Total and Bound Ligands to a Bi-Specific Antibody Mark Jasperse, Research Scientist II, Charles River Immunology |
E‑Guide: Strategic Biomarker Solutions from Early Discovery to Clinical Trials
Unlock biomarker strategies that drive clarity and speed, turning integrated planning and real‑time data into stronger decisions, lower risk, and faster development progress.
Download your copy
Faster, Leaner, Smarter: How Modern CROs Accelerate Your Drug Development
Our on‑demand webinar explains how smarter bioanalysis, lean methods, and automation help you overcome potential bottlenecks, delays, and rising costs.
Watch now
E‑Guide: Bioanalysis from Early‑Stage to Clinical Drug Development
This eGuide reveals a smarter bioanalysis strategy that reduces risk and accelerates decisions, aligning science and timelines across development.
Explore the guide